NO20034182D0 - Kjemiske forbindelser - Google Patents

Kjemiske forbindelser

Info

Publication number
NO20034182D0
NO20034182D0 NO20034182A NO20034182A NO20034182D0 NO 20034182 D0 NO20034182 D0 NO 20034182D0 NO 20034182 A NO20034182 A NO 20034182A NO 20034182 A NO20034182 A NO 20034182A NO 20034182 D0 NO20034182 D0 NO 20034182D0
Authority
NO
Norway
Prior art keywords
chemical connections
connections
chemical
Prior art date
Application number
NO20034182A
Other languages
English (en)
Other versions
NO20034182L (no
Inventor
Adrian Hall
Karamjit Singh Jandu
Christopher James Lunniss
Maria Victoria Vinader
Robert Ian West
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0106871A external-priority patent/GB0106871D0/en
Priority claimed from GB0106875A external-priority patent/GB0106875D0/en
Priority claimed from GB0106877A external-priority patent/GB0106877D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20034182L publication Critical patent/NO20034182L/no
Publication of NO20034182D0 publication Critical patent/NO20034182D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
NO20034182A 2001-03-20 2003-09-19 Kjemiske forbindelser NO20034182D0 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0106871A GB0106871D0 (en) 2001-03-20 2001-03-20 Chemical compounds
GB0106875A GB0106875D0 (en) 2001-03-20 2001-03-20 Medicaments
GB0106877A GB0106877D0 (en) 2001-03-20 2001-03-20 Chemical compounds
PCT/GB2002/001317 WO2002074780A1 (en) 2001-03-20 2002-03-19 Chemical compounds

Publications (2)

Publication Number Publication Date
NO20034182L NO20034182L (no) 2003-09-19
NO20034182D0 true NO20034182D0 (no) 2003-09-19

Family

ID=27256108

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034182A NO20034182D0 (no) 2001-03-20 2003-09-19 Kjemiske forbindelser

Country Status (18)

Country Link
US (1) US20040162422A1 (no)
EP (1) EP1370568B1 (no)
JP (1) JP2004534002A (no)
KR (1) KR20030085014A (no)
CN (1) CN1501941A (no)
AR (1) AR037135A1 (no)
AT (1) ATE306492T1 (no)
BR (1) BR0208169A (no)
CA (1) CA2441202A1 (no)
CZ (1) CZ20032543A3 (no)
DE (1) DE60206605D1 (no)
HU (1) HUP0303533A3 (no)
IL (1) IL157649A0 (no)
MX (1) MXPA03008493A (no)
NO (1) NO20034182D0 (no)
NZ (1) NZ527854A (no)
PL (1) PL364712A1 (no)
WO (1) WO2002074780A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60315164T2 (de) * 2002-08-15 2008-04-30 CV Therapeutics, Inc., Palo Alto Partielle und volle agonisten von a1-adenosinrezeptoren
GB0221694D0 (en) * 2002-09-18 2002-10-30 Glaxo Group Ltd Compounds
GT200500281A (es) * 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
GB0500785D0 (en) 2005-01-14 2005-02-23 Novartis Ag Organic compounds
GB0607944D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607945D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
EP2322525B1 (en) * 2006-04-21 2013-09-18 Novartis AG Purine derivatives for use as adenosin A2A receptor agonists
GB0607953D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607950D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
GB0607948D0 (en) * 2006-04-21 2006-05-31 Novartis Ag Organic compounds
EP1889846A1 (en) 2006-07-13 2008-02-20 Novartis AG Purine derivatives as A2a agonists
EP1903044A1 (en) * 2006-09-14 2008-03-26 Novartis AG Adenosine Derivatives as A2A Receptor Agonists
BRPI0718792A2 (pt) * 2006-11-10 2013-12-03 Novartis Ag Compostos orgânicos
MX2010004234A (es) * 2007-10-17 2010-04-30 Novartis Ag Derivados de purina como ligandos del receptor de adenosina a1.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996308A (en) * 1988-03-25 1991-02-26 Merrell Dow Pharmaceuticals Inc. Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group
GB9723589D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
YU44900A (sh) * 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
GB9813554D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CA2441202A1 (en) 2002-09-26
NO20034182L (no) 2003-09-19
ATE306492T1 (de) 2005-10-15
CZ20032543A3 (en) 2004-05-12
IL157649A0 (en) 2004-05-12
KR20030085014A (ko) 2003-11-01
MXPA03008493A (es) 2003-12-08
HUP0303533A2 (hu) 2004-03-01
HUP0303533A3 (en) 2005-02-28
EP1370568A1 (en) 2003-12-17
WO2002074780A1 (en) 2002-09-26
EP1370568B1 (en) 2005-10-12
NZ527854A (en) 2004-09-24
AR037135A1 (es) 2004-10-27
US20040162422A1 (en) 2004-08-19
JP2004534002A (ja) 2004-11-11
DE60206605D1 (de) 2006-02-23
BR0208169A (pt) 2004-03-02
PL364712A1 (en) 2004-12-13
CN1501941A (zh) 2004-06-02

Similar Documents

Publication Publication Date Title
NO20024774D0 (no) Kjemiske forbindelser
NO20032829L (no) Kjemiske forbindelser
NO20031561D0 (no) Kjemiske forbindelser
DE60232264D1 (de) Suburethrale/zervikale ministütze
NO20033559D0 (no) Basis-smöreolje
ATE524462T1 (de) C5-modifizierte indazolylpyrrolotriazine
NO20043899L (no) Kjemiske forbindelser
NO20030628D0 (no) Kjemiske forbindelser
DE60237872D1 (de) Knetapparat
ATE335486T1 (de) Hydrazono-malonitrile
NO20034182D0 (no) Kjemiske forbindelser
DE60236594D1 (de) Drehströmungsfeuerung
ATE355059T1 (de) Isoxazolopyridinone
NO20013535D0 (no) Nöytrofilfunksjonsinhibitorer
DE60209740D1 (de) Lichstrahlformungsvorrichtung
ATE319694T1 (de) Phenylalkyne
ATA18372001A (de) Gelenksbolzenbaueinheit
FI20012452A0 (fi) Hitsausvirtasuutinmateriaali
ATA13992002A (de) Schlackengranulierungsanlage
ATE405973T1 (de) Steckverbindung
AT500276B1 (de) Radschwenksystem
ATE345337T1 (de) Delta1 -pyrroline
ATA7462001A (de) Radspannwerk
NO20001448L (no) Kjemiske forbindelser
NO20001449D0 (no) Kjemiske forbindelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application